Growing early-stage antibody-drug company - Senior Scientist II Immutics Employee Review

3.0
18 Mar 2022
Recommend
CEO approval
Business outlook

Pros

good pay. fast growing. opportunity to learn how other teams work that are close by.

Cons

very early stage in antibody-drug development

Explore other reviews about Immutics

3.0
2 Nov 2020
Recommend
CEO approval
Business outlook

Pros

Flexibility, excellent teams and potential

Cons

May lack communication and project management

See reviews by: Helpful|Rating|Date|All